CHICAGO-A Japanese study shows laughter may really be the best medicine.
In an experiment, 26 men and women with allergic skin rashes were tested for improvement in the size of their skin welts. The group that watched Charlie Chaplin's "Modern Times" had smaller welts afterward. The group that watched a video on weather had no change in the size of their infections.
Scientists and doctors worldwide have said laughter being a good medicine is not a new discovery. Margaret Stuber, MD, a professor of psychiatry and biobehavioral sciences at UCLA said research has shown stress undermines the disease-fighting immune system. Easing stress has a positive effect.
Japanese researchers based their experiment on a report by author Norman Cousins. Cousins suffered from a life-threatening joint disease and reported that 10 minutes of laughter helped reduce the pain. Cousins 30-year-old research suggested that laughter and a positive attitude can help reduce pain.
Information from www.arizonarepublic.com
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.